President Biden today told a group of G-7 leaders that the U.S. will support the COVAX alliance tasked with distributing COVID-19 vaccines to 92 low- and middle-income countries.

The program is co-administered by the World Health Organization and international vaccine alliance Gavi. The U.S.-contributed funds includes $2 billion appropriated by Congress in December, with an additional $2 billion through 2021 and 2022. The program’s goal is to vaccinate 20% of people living in the 92 target countries.

Related News Articles

Headline
Dr. Trestman and Dr. Hochman reflect on the far-reaching effects of the COVID-19 pandemic on the mental health and well-being of health care professionals,…
Headline
The Food and Drug Administration Friday authorized using the monoclonal antibody therapy REGEN-COV for prevention in certain children and adults who are…
Blog
The American Hospital Association and its Society for Healthcare Strategy and Market Development (SHSMD) July 15 hosted “Addressing COVID-19 Vaccine Hesitancy…
Headline
Read a recap and insights from health care leaders during AHA’s July 15 webinar, “Addressing COVID-19 Vaccine Hesitancy in Your Community,” featuring messaging…
Headline
Three-quarters of the 469 COVID-19 cases associated with summer events and large public gatherings this month in Barnstable County, Mass., were in people fully…
Headline
About 8.9 million children aged 12-17 have received the Pfizer COVID-19 vaccine, the Centers for Disease Control and Prevention reported today. Based on data…